image
CytomX Therapeutics, Inc. CTMX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.91
-9 %
$ 71.2 M
Market Cap
6.07
P/E
BALANCE SHEET
202 M ASSETS
-22.65%
Growth Rates
1Year -22.65%
3Years -17.45%
5Years -15.09%
7Years 0.19%
10Years 30.41%
249 M LIABILITIES
-28.10%
Growth Rates
1Year -28.10%
3Years -6.90%
5Years -5.24%
7Years 10.92%
10Years 15.60%
-47.4 M EQUITY
44.67%
Growth Rates
1Year 44.67%
3Years -24.99%
5Years -6.38%
7Years -6.99%
10Years -0.69%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition CytomX Therapeutics, Inc.
image
Current Assets 183 M
Cash & Short-Term Investments 175 M
Receivables 3.43 M
Other Current Assets 5 M
Non-Current Assets 18.9 M
Long-Term Investments 0
PP&E 16.2 M
Other Non-Current Assets 2.68 M
Current Liabilities 156 M
Accounts Payable 1.46 M
Short-Term Debt 9.18 M
Other Current Liabilities 145 M
Non-Current Liabilities 93.3 M
Long-Term Debt 18.8 M
Other Non-Current Liabilities 74.6 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 17.2 193.7 205.5 191.9 188.4 247.6 177.5 104.6 59.8 64.4 8.7
Short Term Investments 157.3 0 99.7 124.3 107.7 188.6 196.6 77.3 126.9 0 0
Receivables 3.4 36.0 0.8 0.8 13 K 97 K 10.1 2.3 0.7 1.9 0.2
Inventory 0 0 1 1 1 0 1 1 1 100 K 100 K
Other Current Assets 5.0 7.5 8.6 14.2 14.4 18.5 8.7 3.9 4.6 0.6 0.3
Total Current Assets 182.9 237.1 310.3 324.0 303.3 445.5 388.6 188.1 189.8 66.9 9.3
PP&E 16.2 21.0 25.3 29.4 32.8 6.9 4.2 4.4 3.5 3.0 2.1
Intangible Assets 0.7 0.9 1.0 1.2 1.3 1.5 1.6 1.8 1.8 1.8 1.8
Goodwill 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
Long Term Investments 0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 0 0
Other Long Term Assets 1.0 (3.6) (3.7) (3.4) 2.9 0.2 1.0 2.7 (0.1) 0.5 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 201.8 260.9 339.4 358.7 341.3 457.1 397.6 199.1 197.2 73.1 14.2
LIABILITIES
Accounts Payable 1.5 2.8 2.8 3.0 4.2 5.1 4.2 6.6 4.7 1.9 0.9
Short Term Debt 9.2 4.1 3.6 3.2 2.8 0 0 0 0 1.4 1.3
Other Current Liabilities 17.9 24.4 30.6 19.9 27.2 26.7 16.4 8.8 4.9 1.7 1.1
Total Current Liabilities 155.9 152.6 106.3 100.9 85.6 97.9 61.1 35.8 15.7 11.2 4.2
Long Term Debt 18.8 27.9 36.1 43.4 49.7 0 0 0 0 1.6 2.9
Deferred Tax Income (9.4) 3.6 4.6 5.5 0 1.1 0.4 0.5 0.5 0.5 0.5
Other Liabilities (5.5) (14.0) 100.2 (21.7) (24.0) 3.0 1.9 0.6 0.2 77.5 46.2
Total Liabilities 249.2 346.6 250.0 308.9 290.2 326.2 327.7 120.6 71.1 151.6 58.5
EQUITY
Common Stock 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K
Retained Earnings (723.4) (722.9) (533.7) (450.1) (417.2) (315.0) (219.5) (176.4) (117.5) (78.1) (43.9)
Other Accumulative Comprehensive Income/Loss 95 K 10 K (0.2) 47 K 57 K 93 K 94 K 27 K 76 K (0.4) (0.4)
Total Equity (47.4) (85.8) 89.4 49.8 51.1 130.9 69.9 78.5 126.1 (78.5) (44.3)
Total Liabilities and Equity 201.8 260.9 339.4 358.7 341.3 457.1 397.6 199.1 197.2 73.1 14.2
SHARES OUTSTANDING
Common Shares Outstanding 73.8 65.7 64.1 46.1 45.3 41.7 37.2 36.2 8.6 34.9 34.9